DOCS Jan 2024 57.500 call
| Previous close | 3.3600 |
| Open | 3.3600 |
| Bid | 3.2000 |
| Ask | 3.6000 |
| Strike | 57.50 |
| Expiry date | 2024-01-19 |
| Day's range | 3.9100 - 3.9100 |
| Contract range | N/A |
| Volume | |
| Open interest | 11 |
- Motley Fool
3 Smart Tech Stocks to Buy in 2022 and Beyond
Three smart buys right now are Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG), Block (NYSE: SQ), and Doximity (NYSE: DOCS). Alphabet, parent of internet search engine Google, needs little introduction. Over the last two-decades-plus, Google's digital advertising-fueled empire has managed to steadily grow in good times and bad.
- Motley Fool
Doximity Stock: Bull vs. Bear
Doximity (NYSE: DOCS), which owns and operates the largest digital platform for U.S. medical professionals, is a prime example. The company's stock price is presently down by an eye-catching 60.9% relative to its all-time highs. Should bargain hunters pounce on this downtrodden growth stock, or is it better to watch this falling knife from the sidelines?
- Motley Fool
Amazon Lost Signify: 3 Healthcare Companies That May Be Better Options
Tech giant Amazon (NASDAQ: AMZN) was in the bidding for home health company Signify Health but ended up losing out to CVS Health. It may have been a disappointment for investors who were hoping Amazon would deepen its footprint in healthcare. GoodRx sits atop this list because it could be the best fit for Amazon.
